These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15755472)

  • 1. Drug dosing in chronic kidney disease.
    Gabardi S; Abramson S
    Med Clin North Am; 2005 May; 89(3):649-87. PubMed ID: 15755472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiotics dosing strategies in chronic kidney disease].
    Bourquin V
    Rev Med Suisse; 2007 Oct; 3(128):2280-2, 2284-8. PubMed ID: 17985604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug dosing adjustments in patients with chronic kidney disease.
    Munar MY; Singh H
    Am Fam Physician; 2007 May; 75(10):1487-96. PubMed ID: 17555141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medications in the kidney.
    Scheen AJ
    Acta Clin Belg; 2008; 63(2):76-80. PubMed ID: 18575046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug dosing guidelines in patients with renal failure.
    Swan SK; Bennett WM
    West J Med; 1992 Jun; 156(6):633-8. PubMed ID: 1615656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative approach to drug dosing in chronic kidney disease.
    Olyaei AJ; Steffl JL
    Blood Purif; 2011; 31(1-3):138-45. PubMed ID: 21228582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal function and pharmacotherapy in children].
    Jovanović O
    Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():15-21. PubMed ID: 18193796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing drug development and use in patients with kidney disease.
    Nolin TD; Arya V; Sitar DS; Pfister M
    J Clin Pharmacol; 2011 May; 51(5):628-30. PubMed ID: 21525394
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics in patients with renal failure.
    Maher JF
    Clin Nephrol; 1984 Jan; 21(1):39-46. PubMed ID: 6368069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review on pharmacokinetics and pharmacodynamics and the aging kidney.
    Aymanns C; Keller F; Maus S; Hartmann B; Czock D
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):314-27. PubMed ID: 20056753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected pharmacokinetic issues in patients with chronic kidney disease.
    Churchwell MD; Mueller BA
    Blood Purif; 2007; 25(1):133-8. PubMed ID: 17170551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of renal failure in the pathogenesis of adverse drug reactions in the elderly].
    Corsonello A; Pedone C; Corica F; Mazzei B; Mussi C; Di Iorio A; Incalzi RA
    Recenti Prog Med; 2006 Feb; 97(2):90-3. PubMed ID: 16671275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered nonrenal drug clearance in ESRD.
    Nolin TD
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):555-9. PubMed ID: 18941346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic bases of dosage adaptation of drugs in renal insufficiency].
    Lesne M
    J Pharm Belg; 1988; 43(3):212-32. PubMed ID: 3171871
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonrenal drug clearance in CKD: Searching for the path less traveled.
    Momper JD; Venkataramanan R; Nolin TD
    Adv Chronic Kidney Dis; 2010 Sep; 17(5):384-91. PubMed ID: 20727508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
    Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
    Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of chronic renal failure on drug metabolism and transport.
    Dreisbach AW
    Clin Pharmacol Ther; 2009 Nov; 86(5):553-6. PubMed ID: 19776735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.